New Risk • May 26
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.3% Last year net profit margin: 1.3% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (0.3% net profit margin). Market cap is less than US$100m (₩48.2b market cap, or US$31.8m). Annuncio • Mar 07
Shinwha Intertek Corp., Annual General Meeting, Mar 26, 2026 Shinwha Intertek Corp., Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 308, maebong-ro, byeongcheon-myeon, dongnam-gu, chungcheongnam-do, cheonan South Korea Reported Earnings • Nov 16
Third quarter 2025 earnings released: EPS: ₩41.00 (vs ₩30.00 loss in 3Q 2024) Third quarter 2025 results: EPS: ₩41.00 (up from ₩30.00 loss in 3Q 2024). Revenue: ₩55.3b (down 22% from 3Q 2024). Net income: ₩1.20b (up ₩2.07b from 3Q 2024). Profit margin: 2.2% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 75% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 15
Second quarter 2025 earnings released: EPS: ₩69.00 (vs ₩1.00 loss in 2Q 2024) Second quarter 2025 results: EPS: ₩69.00 (up from ₩1.00 loss in 2Q 2024). Revenue: ₩54.6b (down 7.2% from 2Q 2024). Net income: ₩2.01b (up ₩2.03b from 2Q 2024). Profit margin: 3.7% (up from 0% in 2Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings. Reported Earnings • May 20
First quarter 2025 earnings released: EPS: ₩86.00 (vs ₩4.00 in 1Q 2024) First quarter 2025 results: EPS: ₩86.00 (up from ₩4.00 in 1Q 2024). Revenue: ₩66.1b (up 15% from 1Q 2024). Net income: ₩2.51b (up ₩2.40b from 1Q 2024). Profit margin: 3.8% (up from 0.2% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Reported Earnings • Mar 20
Full year 2024 earnings released: EPS: ₩29.00 (vs ₩559 loss in FY 2023) Full year 2024 results: EPS: ₩29.00 (up from ₩559 loss in FY 2023). Revenue: ₩247.4b (up 39% from FY 2023). Net income: ₩844.6m (up ₩17.1b from FY 2023). Profit margin: 0.3% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings. Annuncio • Mar 06
Shinwha Intertek Corp., Annual General Meeting, Mar 26, 2025 Shinwha Intertek Corp., Annual General Meeting, Mar 26, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 308, maebong-ro, byeongcheon-myeon, dongnam-gu, chungcheongnam-do, cheonan South Korea Reported Earnings • Nov 15
Third quarter 2024 earnings released: ₩30.00 loss per share (vs ₩151 loss in 3Q 2023) Third quarter 2024 results: ₩30.00 loss per share (improved from ₩151 loss in 3Q 2023). Revenue: ₩71.1b (up 33% from 3Q 2023). Net loss: ₩865.9m (loss narrowed 80% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 51% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 16
Second quarter 2024 earnings released: ₩1.00 loss per share (vs ₩128 loss in 2Q 2023) Second quarter 2024 results: ₩1.00 loss per share (improved from ₩128 loss in 2Q 2023). Revenue: ₩58.9b (up 57% from 2Q 2023). Net loss: ₩24.4m (loss narrowed 99% from 2Q 2023). Profit margin: 0% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance. Reported Earnings • May 19
First quarter 2024 earnings released: EPS: ₩4.00 (vs ₩187 loss in 1Q 2023) First quarter 2024 results: EPS: ₩4.00 (up from ₩187 loss in 1Q 2023). Revenue: ₩57.4b (up 42% from 1Q 2023). Net income: ₩102.5m (up ₩5.54b from 1Q 2023). Profit margin: 0.2% (up from net loss in 1Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance. New Risk • Feb 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 55% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩79.3b market cap, or US$59.9m). Reported Earnings • Mar 26
Full year 2022 earnings released: ₩290 loss per share (vs ₩39.00 profit in FY 2021) Full year 2022 results: ₩290 loss per share (down from ₩39.00 profit in FY 2021). Revenue: ₩201.2b (down 18% from FY 2021). Net loss: ₩8.41b (down ₩9.53b from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 107 percentage points per year, which is a significant difference in performance. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Valuation Update With 7 Day Price Move • Sep 29
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩3,140, the stock trades at a trailing P/E ratio of 37.9x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 22% over the past three years. Valuation Update With 7 Day Price Move • Jun 16
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₩2,540, the stock trades at a trailing P/E ratio of 67.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 56% over the past three years. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Upcoming Dividend • Dec 22
Upcoming dividend of ₩50.00 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 21 April 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 1.7%. Lower than top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%). Reported Earnings • Mar 20
Full year 2020 earnings released: EPS ₩115 (vs ₩327 in FY 2019) The company reported a poor full year result with weaker earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: ₩255.3b (flat on FY 2019). Net income: ₩3.33b (down 65% from FY 2019). Profit margin: 1.3% (down from 3.7% in FY 2019). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Jan 27
New 90-day high: ₩4,220 The company is up 60% from its price of ₩2,640 on 29 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 38% over the same period. Valuation Update With 7 Day Price Move • Jan 12
Investor sentiment improved over the past week After last week's 17% share price gain to ₩4,000, the stock is trading at a trailing P/E ratio of 57.4x, up from the previous P/E ratio of 48.9x. This compares to an average P/E of 16x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 75%. Is New 90 Day High Low • Jan 04
New 90-day high: ₩3,395 The company is up 27% from its price of ₩2,670 on 06 October 2020. The South Korean market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period. Is New 90 Day High Low • Dec 17
New 90-day high: ₩3,295 The company is up 19% from its price of ₩2,775 on 18 September 2020. The South Korean market is up 14% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 20% over the same period. Is New 90 Day High Low • Dec 02
New 90-day high: ₩3,100 The company is up 18% from its price of ₩2,635 on 03 September 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. Reported Earnings • Nov 19
Third quarter 2020 earnings released: EPS ₩203 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: ₩84.3b (up 23% from 3Q 2019). Net income: ₩5.90b (up 123% from 3Q 2019). Profit margin: 7.0% (up from 3.9% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Annuncio • Sep 21
Shinwha Intertek Corp.(KOSDAQ:A056700) dropped from S&P Global BMI Index Shinwha Intertek Corp.(KOSDAQ:A056700) dropped from S&P Global BMI Index